LabConnect collaborates with Symphony to support clinical research industry

LabConnect, LLC, a leading global provider of central laboratory and support services for biopharmaceutical, medical device and contract research organizations, and Symphony Clinical Research, a worldwide, innovative in-home clinical service provider, today announced a strategic collaboration. The two companies have worked together on 17 studies over 12 years and will now focus on seamlessly integrating company services to support the clinical research industry.

By changing the place of the clinical trial to the patient's home, office or destination, Symphony supports study sponsors, removing barriers to their trials by enhancing enrollment and retention. In-home visits greatly improve trials for patients, allowing them to associate the clinical trial process with a place of comfort and convenience.

"Our commitment to excellence drives the collaboration between Symphony and LabConnect," said Nicki Norris, CEO of Symphony Clinical Research. "Together we make patient-centric clinical trials possible."

LabConnect, which offers extensive clinical trial services to support investigative sites, will provide customized clinical kits, specialized laboratory testing, PBMC processing, reporting and logistical expertise to expand alternative site testing to more areas of the international community.

"We value long-term successful relationships and our 12-year collaboration with Symphony exemplifies this," said Eric Hayashi, CEO of LabConnect. "Together we're dramatically changing clinical trial conduct — ultimately helping to bring new medications to market more quickly, efficiently and cost-effectively and improving lives across the globe."

The collaboration will streamline clients' clinical trial conduct through co-developed processes and tools, such as improving clinical kit designs for home health nurses, streamlining reporting for home visits and optimizing clinical collection kit logistics including inbound and outbound shipping. In addition, LabConnect and Symphony will develop client informational materials to educate all stakeholders throughout the process.

Source:https://www.labconnectllc.com/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Patient-derived organoids: Transforming cancer research and personalized medicine